Rearrangement of KMT2A Characterizes a Subset of Pediatric Parotid Mucoepidermoid Carcinomas Arising Metachronous to Acute Lymphoblastic Leukemia
Language English Country Great Britain, England Media print-electronic
Document type Journal Article
- Keywords
- KMT2A gene, MAML2 gene, metachronous mucoepidermoid carcinoma, pediatric leukemia, salivary gland cancer,
- MeSH
- Precursor Cell Lymphoblastic Leukemia-Lymphoma * MeSH
- Child MeSH
- DNA-Binding Proteins genetics MeSH
- Gene Rearrangement MeSH
- Nuclear Proteins genetics MeSH
- Humans MeSH
- Young Adult MeSH
- Carcinoma, Mucoepidermoid * genetics pathology MeSH
- Trans-Activators genetics MeSH
- Check Tag
- Child MeSH
- Humans MeSH
- Young Adult MeSH
- Publication type
- Journal Article MeSH
- Names of Substances
- DNA-Binding Proteins MeSH
- Nuclear Proteins MeSH
- Trans-Activators MeSH
Introduction: Metachronous mucoepidermoid carcinomas (MMEC) may occur in association with childhood leukemias and lymphomas. We compared molecular abnormalities of MMEC in patients with ALL with the abnormalities found in primary mucoepidermoid carcinomas (MECs) in pediatric cases and young adults. Materials and methods: Immunohistochemical stains for p63 and SOX10, molecular alterations in MAML2 and KMT2A genes detected by FISH and/or next-generation sequencing were studied in 12 pediatric MMECs secondary to ALL and six primary MECs in pediatric patients and young adults. Follow-up information of patients in both groups was obtained. Results: KMT2A rearrangements were detected in pediatric MMECs, and they were associated with remarkable histomorphological changes, including deposits of abundant stromal collagen and intratumoral lymphoid proliferations. No KMT2A rearrangements were found in primary MECs. The prognosis of MMEC in patients with ALL, especially in KMT2A-rearranged cases, was worse than in primary MECs. Kruskal-Wallis test showed a statistically significant difference in overall survival between KMT2A-rearranged MMECs and KMT2A-intact MMECs in cases with ALL (p = 0.027). Conclusion: KMT2A-rearranged MMECs in ALL patients may have inherently more aggressive behavior, even when the histomorphology of MMEC suggests a low-grade malignancy.
Department of Pathology Bioptic Laboratory Ltd Pilsen Czech Republic
Department of Pathology Charles University Faculty of Medicine in Pilsen Pilsen Czech Republic
Institute of Biomedicine Pathology University of Turku and Turku University Hospital Turku Finland
Molecular Genetic Laboratory Bioptic Laboratory Pilsen Czech Republic
References provided by Crossref.org
Molecular pathology in diagnosis and prognostication of head and neck tumors